K0706 for Patients Diagnosed With Dementia With Lewy Bodies | MicrobiomeTrials← Back to trialsNCT03996460
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
TERMINATEDPHASE2INTERVENTIONAL
Trial Details
Start: 2019-09-05Est. Completion: 2024-04-22
Enrollment target: 29 participants Locations- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
Other microbiome trials you might be interested in
Patients With SynucleinopathiesNeurogenic Orthostatic HypotensionPure Autonomic FailureREM Sleep Behavior DisorderParkinson DiseaseDementia With Lewy BodiesMultiple System AtrophyShy-Drager Disease
Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumula…
Boston, United StatesEst. completion Dec 30, 2026
REM Sleep Behavior Disorder
REM sleep behavior disorder is a parasomnia that reflects the presence of alpha-synucleinopathy in the brain and is high…
Minneapolis, United States
Est. completion Jul 31, 2027
Lewy Bodies DiseaseDepression DisorderCaregiver BurdenCaregivers
This study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in fam…
Seattle, United StatesEst. completion Nov 30, 2029